Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Virpax Pharmaceuticals (VRPX)
NASDAQ:VRPX
RESEARCH TOOLSreports
Virpax Pharmaceuticals (VRPX) Stock Price & Analysis
90 Followers
VRPX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.46 - $10.01
Previous Close$1.36
Volume1.50M
Average Volume (3M)4.98M
Market Cap
$3.86M
Enterprise Value-$5.28M
Total Cash (Recent Filing)$9.14M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Aug 12, 2024EPS Estimate
-$1.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.42
Shares Outstanding1,171,233
10 Day Avg. Volume443,027
30 Day Avg. Volume4,976,021
Standard Deviation0.60
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.09
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Virpax Pharmaceuticals News
PremiumMarket News
3 Penny Stocks to Watch Now, 7/23/24
PremiumCompany Announcements
Virpax Pharmaceuticals’ Strategic Financing and Board Reshaping
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VRPX FAQ
What was Virpax Pharmaceuticals’s price range in the past 12 months?
Virpax Pharmaceuticals lowest stock price was $0.46 and its highest was $10.01 in the past 12 months.
What is Virpax Pharmaceuticals’s market cap?
Currently, no data Available
When is Virpax Pharmaceuticals’s upcoming earnings report date?
Virpax Pharmaceuticals’s upcoming earnings report date is Aug 12, 2024 which is in 18 days.
How were Virpax Pharmaceuticals’s earnings last quarter?
Virpax Pharmaceuticals released its earnings results on May 13, 2024. The company reported -$2.75 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.75.
Is Virpax Pharmaceuticals overvalued?
According to Wall Street analysts Virpax Pharmaceuticals’s price is currently Overvalued.
Does Virpax Pharmaceuticals pay dividends?
Virpax Pharmaceuticals does not currently pay dividends.
What is Virpax Pharmaceuticals’s EPS estimate?
Virpax Pharmaceuticals’s EPS estimate is -$1.53.
How many shares outstanding does Virpax Pharmaceuticals have?
Virpax Pharmaceuticals has 2,837,898 shares outstanding.
What happened to Virpax Pharmaceuticals’s price movement after its last earnings report?
Virpax Pharmaceuticals reported an EPS of -$2.75 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -24.671%.
Which hedge fund is a major shareholder of Virpax Pharmaceuticals?
Currently, no hedge funds are holding shares in VRPX
---
Virpax Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.66%
12-Months-Change
Fundamentals
Return on Equity
-241.52%
Trailing 12-Months
Asset Growth
-83.07%
Trailing 12-Months
Company Description
Virpax Pharmaceuticals
Virpax Pharmaceuticals Inc is a preclinical-stage pharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management.
---
VRPX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---